866-997-4948(US-Canada Toll Free)

Global Microbiome Drugs Market Size, Status and Forecast 2018-2025

Published By :

QYResearch

Published Date : Sep 2018

Category :

Software

No. of Pages : 94 Pages

This report focuses on the global Microbiome Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Microbiome Drugs development in United States, Europe and China.

In 2017, the global Microbiome Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

The key players covered in this study
Pfizer
Second Genome
Seres Therapeutics
MaaT Pharma
Enterome Bioscience
MicroBiome Therapeutics
Ritter Pharmaceuticals
Rebiotix
OpenBiome

Market segment by Type, the product can be split into
Probiotics
Prebiotics
Small Molecules
Biological Drugs
Other

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Microbiome Drugs status, future forecast, growth opportunity, key market and key players.
To present the Microbiome Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Microbiome Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Microbiome Drugs Market Size Growth Rate by Type (2013-2025)
1.4.2 Probiotics
1.4.3 Prebiotics
1.4.4 Small Molecules
1.4.5 Biological Drugs
1.4.6 Other
1.5 Market by Application
1.5.1 Global Microbiome Drugs Market Share by Application (2013-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Microbiome Drugs Market Size
2.2 Microbiome Drugs Growth Trends by Regions
2.2.1 Microbiome Drugs Market Size by Regions (2013-2025)
2.2.2 Microbiome Drugs Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Microbiome Drugs Market Size by Manufacturers
3.1.1 Global Microbiome Drugs Revenue by Manufacturers (2013-2018)
3.1.2 Global Microbiome Drugs Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Microbiome Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Microbiome Drugs Key Players Head office and Area Served
3.3 Key Players Microbiome Drugs Product/Solution/Service
3.4 Date of Enter into Microbiome Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Microbiome Drugs Market Size by Type (2013-2018)
4.2 Global Microbiome Drugs Market Size by Application (2013-2018)

5 United States
5.1 United States Microbiome Drugs Market Size (2013-2018)
5.2 Microbiome Drugs Key Players in United States
5.3 United States Microbiome Drugs Market Size by Type
5.4 United States Microbiome Drugs Market Size by Application

6 Europe
6.1 Europe Microbiome Drugs Market Size (2013-2018)
6.2 Microbiome Drugs Key Players in Europe
6.3 Europe Microbiome Drugs Market Size by Type
6.4 Europe Microbiome Drugs Market Size by Application

7 China
7.1 China Microbiome Drugs Market Size (2013-2018)
7.2 Microbiome Drugs Key Players in China
7.3 China Microbiome Drugs Market Size by Type
7.4 China Microbiome Drugs Market Size by Application

8 Japan
8.1 Japan Microbiome Drugs Market Size (2013-2018)
8.2 Microbiome Drugs Key Players in Japan
8.3 Japan Microbiome Drugs Market Size by Type
8.4 Japan Microbiome Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Microbiome Drugs Market Size (2013-2018)
9.2 Microbiome Drugs Key Players in Southeast Asia
9.3 Southeast Asia Microbiome Drugs Market Size by Type
9.4 Southeast Asia Microbiome Drugs Market Size by Application

10 India
10.1 India Microbiome Drugs Market Size (2013-2018)
10.2 Microbiome Drugs Key Players in India
10.3 India Microbiome Drugs Market Size by Type
10.4 India Microbiome Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Microbiome Drugs Market Size (2013-2018)
11.2 Microbiome Drugs Key Players in Central & South America
11.3 Central & South America Microbiome Drugs Market Size by Type
11.4 Central & South America Microbiome Drugs Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Microbiome Drugs Introduction
12.1.4 Pfizer Revenue in Microbiome Drugs Business (2013-2018)
12.1.5 Pfizer Recent Development
12.2 Second Genome
12.2.1 Second Genome Company Details
12.2.2 Company Description and Business Overview
12.2.3 Microbiome Drugs Introduction
12.2.4 Second Genome Revenue in Microbiome Drugs Business (2013-2018)
12.2.5 Second Genome Recent Development
12.3 Seres Therapeutics
12.3.1 Seres Therapeutics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Microbiome Drugs Introduction
12.3.4 Seres Therapeutics Revenue in Microbiome Drugs Business (2013-2018)
12.3.5 Seres Therapeutics Recent Development
12.4 MaaT Pharma
12.4.1 MaaT Pharma Company Details
12.4.2 Company Description and Business Overview
12.4.3 Microbiome Drugs Introduction
12.4.4 MaaT Pharma Revenue in Microbiome Drugs Business (2013-2018)
12.4.5 MaaT Pharma Recent Development
12.5 Enterome Bioscience
12.5.1 Enterome Bioscience Company Details
12.5.2 Company Description and Business Overview
12.5.3 Microbiome Drugs Introduction
12.5.4 Enterome Bioscience Revenue in Microbiome Drugs Business (2013-2018)
12.5.5 Enterome Bioscience Recent Development
12.6 MicroBiome Therapeutics
12.6.1 MicroBiome Therapeutics Company Details
12.6.2 Company Description and Business Overview
12.6.3 Microbiome Drugs Introduction
12.6.4 MicroBiome Therapeutics Revenue in Microbiome Drugs Business (2013-2018)
12.6.5 MicroBiome Therapeutics Recent Development
12.7 Ritter Pharmaceuticals
12.7.1 Ritter Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Microbiome Drugs Introduction
12.7.4 Ritter Pharmaceuticals Revenue in Microbiome Drugs Business (2013-2018)
12.7.5 Ritter Pharmaceuticals Recent Development
12.8 Rebiotix
12.8.1 Rebiotix Company Details
12.8.2 Company Description and Business Overview
12.8.3 Microbiome Drugs Introduction
12.8.4 Rebiotix Revenue in Microbiome Drugs Business (2013-2018)
12.8.5 Rebiotix Recent Development
12.9 OpenBiome
12.9.1 OpenBiome Company Details
12.9.2 Company Description and Business Overview
12.9.3 Microbiome Drugs Introduction
12.9.4 OpenBiome Revenue in Microbiome Drugs Business (2013-2018)
12.9.5 OpenBiome Recent Development

13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Table

List of Tables and Figures

Table Microbiome Drugs Key Market Segments
Table Key Players Microbiome Drugs Covered
Table Global Microbiome Drugs Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Microbiome Drugs Market Size Market Share by Type 2013-2025
Figure Probiotics Figures
Table Key Players of Probiotics
Figure Prebiotics Figures
Table Key Players of Prebiotics
Figure Small Molecules Figures
Table Key Players of Small Molecules
Figure Biological Drugs Figures
Table Key Players of Biological Drugs
Figure Other Figures
Table Key Players of Other
Table Global Microbiome Drugs Market Size Growth by Application 2013-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Other Case Studies
Figure Microbiome Drugs Report Years Considered
Table Global Microbiome Drugs Market Size 2013-2025 (Million US$)
Figure Global Microbiome Drugs Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Microbiome Drugs Market Size by Regions 2013-2025 (Million US$)
Table Global Microbiome Drugs Market Size by Regions 2013-2018 (Million US$)
Table Global Microbiome Drugs Market Share by Regions 2013-2018
Figure Global Microbiome Drugs Market Share by Regions 2013-2018
Figure Global Microbiome Drugs Market Share by Regions 2018
Table Market Top Trends
Table Global Microbiome Drugs Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Microbiome Drugs Market Share by Manufacturers (2013-2018)
Figure Global Microbiome Drugs Market Share by Manufacturers in 2018
Table Global Microbiome Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Microbiome Drugs Product/Solution/Service
Table Date of Enter into Microbiome Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Microbiome Drugs Market Size by Type (2013-2018) (Million US$)
Table Global Microbiome Drugs Market Size Share by Type (2013-2018)
Figure Global Microbiome Drugs Market Size Market Share by Type (2013-2018)
Table Global Microbiome Drugs Market Size by Application (2013-2018) (Million US$)
Table Global Microbiome Drugs Market Size Share by Application (2013-2018)
Figure Global Microbiome Drugs Market Size Market Share by Application (2013-2018)
Figure Global Microbiome Drugs Revenue Market Share by Application in 2017
Figure United States Microbiome Drugs Market Size 2013-2018 (Million US$)
Table United States Key Players Microbiome Drugs Revenue (2017-2018) (Million US$)
Table United States Key Players Microbiome Drugs Market Share (2017-2018)
Table United States Microbiome Drugs Market Size by Type (2013-2018) (Million US$)
Table United States Microbiome Drugs Market Share by Type (2013-2018)
Table United States Microbiome Drugs Market Size by Application (2013-2018) (Million US$)
Table United States Microbiome Drugs Market Share by Application (2013-2018)
Figure Europe Microbiome Drugs Market Size 2013-2018 (Million US$)
Table Europe Key Players Microbiome Drugs Revenue (2017-2018) (Million US$)
Table Europe Key Players Microbiome Drugs Market Share (2017-2018)
Table Europe Microbiome Drugs Market Size by Type (2013-2018) (Million US$)
Table Europe Microbiome Drugs Market Share by Type (2013-2018)
Table Europe Microbiome Drugs Market Size by Application (2013-2018) (Million US$)
Table Europe Microbiome Drugs Market Share by Application (2013-2018)
Figure China Microbiome Drugs Market Size 2013-2018 (Million US$)
Table China Key Players Microbiome Drugs Revenue (2017-2018) (Million US$)
Table China Key Players Microbiome Drugs Market Share (2017-2018)
Table China Microbiome Drugs Market Size by Type (2013-2018) (Million US$)
Table China Microbiome Drugs Market Share by Type (2013-2018)
Table China Microbiome Drugs Market Size by Application (2013-2018) (Million US$)
Table China Microbiome Drugs Market Share by Application (2013-2018)
Figure Japan Microbiome Drugs Market Size 2013-2018 (Million US$)
Table Japan Key Players Microbiome Drugs Revenue (2017-2018) (Million US$)
Table Japan Key Players Microbiome Drugs Market Share (2017-2018)
Table Japan Microbiome Drugs Market Size by Type (2013-2018) (Million US$)
Table Japan Microbiome Drugs Market Share by Type (2013-2018)
Table Japan Microbiome Drugs Market Size by Application (2013-2018) (Million US$)
Table Japan Microbiome Drugs Market Share by Application (2013-2018)
Figure Southeast Asia Microbiome Drugs Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Microbiome Drugs Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Microbiome Drugs Market Share (2017-2018)
Table Southeast Asia Microbiome Drugs Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Microbiome Drugs Market Share by Type (2013-2018)
Table Southeast Asia Microbiome Drugs Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Microbiome Drugs Market Share by Application (2013-2018)
Figure India Microbiome Drugs Market Size 2013-2018 (Million US$)
Table India Key Players Microbiome Drugs Revenue (2017-2018) (Million US$)
Table India Key Players Microbiome Drugs Market Share (2017-2018)
Table India Microbiome Drugs Market Size by Type (2013-2018) (Million US$)
Table India Microbiome Drugs Market Share by Type (2013-2018)
Table India Microbiome Drugs Market Size by Application (2013-2018) (Million US$)
Table India Microbiome Drugs Market Share by Application (2013-2018)
Figure Central & South America Microbiome Drugs Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Microbiome Drugs Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Microbiome Drugs Market Share (2017-2018)
Table Central & South America Microbiome Drugs Market Size by Type (2013-2018) (Million US$)
Table Central & South America Microbiome Drugs Market Share by Type (2013-2018)
Table Central & South America Microbiome Drugs Market Size by Application (2013-2018) (Million US$)
Table Central & South America Microbiome Drugs Market Share by Application (2013-2018)
Table Pfizer Company Details
Table Pfizer Revenue in Microbiome Drugs Business (2013-2018) (Million US$)
Figure Pfizer Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
Table Pfizer Recent Development
Table Second Genome Company Details
Table Second Genome Revenue in Microbiome Drugs Business (2013-2018)(Million US$)
Figure Second Genome Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
Table Second Genome Recent Development
Table Seres Therapeutics Company Details
Table Seres Therapeutics Revenue in Microbiome Drugs Business (2013-2018)(Million US$)
Figure Seres Therapeutics Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
Table Seres Therapeutics Recent Development
Table MaaT Pharma Company Details
Table MaaT Pharma Revenue in Microbiome Drugs Business (2013-2018)(Million US$)
Figure MaaT Pharma Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
Table MaaT Pharma Recent Development
Table Enterome Bioscience Company Details
Table Enterome Bioscience Revenue in Microbiome Drugs Business (2013-2018)(Million US$)
Figure Enterome Bioscience Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
Table Enterome Bioscience Recent Development
Table MicroBiome Therapeutics Company Details
Table MicroBiome Therapeutics Revenue in Microbiome Drugs Business (2013-2018)(Million US$)
Figure MicroBiome Therapeutics Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
Table MicroBiome Therapeutics Recent Development
Table Ritter Pharmaceuticals Company Details
Table Ritter Pharmaceuticals Revenue in Microbiome Drugs Business (2013-2018)(Million US$)
Figure Ritter Pharmaceuticals Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
Table Ritter Pharmaceuticals Recent Development
Table Rebiotix Company Details
Table Rebiotix Revenue in Microbiome Drugs Business (2013-2018)(Million US$)
Figure Rebiotix Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
Table Rebiotix Recent Development
Table OpenBiome Company Details
Table OpenBiome Revenue in Microbiome Drugs Business (2013-2018)(Million US$)
Figure OpenBiome Revenue Growth Rate in Microbiome Drugs Business (2013-2018)
Table OpenBiome Recent Development
Table Global Microbiome Drugs Market Size by Regions (Million US$) 2018-2025
Figure Global Microbiome Drugs Market Size Share by Regions (2018-2025)
Figure Global Microbiome Drugs Market Size Share by Regions in 2025
Figure United States Microbiome Drugs Market Size Forecast (2018-2025)(Million USD)
Figure Europe Microbiome Drugs Market Size Forecast (2018-2025)(Million USD)
Figure China Microbiome Drugs Market Size Forecast (2018-2025)(Million USD)
Figure Japan Microbiome Drugs Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Microbiome Drugs Market Size Forecast (2018-2025)(Million USD)
Figure India Microbiome Drugs Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Microbiome Drugs Market Size Forecast (2018-2025)(Million USD)
Table Global Microbiome Drugs Market Size by Product (2018-2025) (Million US$)
Figure Global Microbiome Drugs Market Size by Product (2018-2025)
Figure Global Microbiome Drugs Market Size by Product in 2025
Table Global Microbiome Drugs Market Size by Application (2018-2025) (Million US$)
Figure Global Microbiome Drugs Market Size by Application (2018-2025)
Figure Global Microbiome Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *